Gilead Sciences
GILD
#129
Rank
ยฃ112.90 B
Marketcap
ยฃ90.99
Share price
-1.14%
Change (1 day)
27.14%
Change (1 year)

Revenue for Gilead Sciences (GILD)

Revenue in 2025 (TTM): ยฃ22.12 Billion

According to Gilead Sciences's latest financial reports the company's current revenue (TTM ) is ยฃ21.83 Billion. In 2024 the company made a revenue of ยฃ22.91 Billion an increase over the revenue in the year 2023 that were of ยฃ21.28 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Gilead Sciences from 1996 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ22.12 B-3.43%
2024 ยฃ22.91 B7.65%
2023 ยฃ21.28 B-5.62%
2022 ยฃ22.55 B11.48%
2021 ยฃ20.22 B11.68%
2020 ยฃ18.11 B5.8%
2019 ยฃ17.11 B-1.79%
2018 ยฃ17.43 B-9.76%
2017 ยฃ19.31 B-21.57%
2016 ยฃ24.62 B11.82%
2015 ยฃ22.02 B37.77%
2014 ยฃ15.98 B135.42%
2013 ยฃ6.79 B13.13%
2012 ยฃ6.00 B11.27%
2011 ยฃ5.39 B4.77%
2010 ยฃ5.14 B18.85%
2009 ยฃ4.33 B19.01%
2008 ยฃ3.64 B70.98%
2007 ยฃ2.12 B37.82%
2006 ยฃ1.54 B31.34%
2005 ยฃ1.17 B70.48%
2004 ยฃ0.68 B42.22%
2003 ยฃ0.48 B66.65%
2002 ยฃ0.29 B80.56%
2001 ยฃ0.16 B21.41%
2000 ยฃ0.13 B26.95%
1999 ยฃ0.10 B182.81%
1998 ยฃ36.98 M51.89%
1997 ยฃ24.35 M24.46%
1996 ยฃ19.56 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Amgen
AMGN
ยฃ27.00 B 23.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
ยฃ8.80 B-59.69%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
ยฃ44.77 B 105.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
ยฃ3.21 B-85.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
ยฃ7.55 B-65.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ47.13 B 115.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ69.17 B 216.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ44.60 B 104.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ48.21 B 120.85%๐Ÿ‡บ๐Ÿ‡ธ USA